Zusammensetzung information
Zusammensetzung, Synonyme
- Immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer s patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus κ-chain, dimer
- MLN0002 (Takeda)
- MLN02
- LDP02
- Vedolizumabum
- Immunoglobulin G1-kappa, anti-[Homo sapiens alpha4 beta7 integrin (lymphocyte Peyer s patch adhesion molecule 1, LPAM-1)], humanized monoclonal antibody; gamma1 heavy chain (1-451) [humanized VH (Homo sapiens IGHV1-3*01 (84.70%)-(IGHD)-IGHJ4*01) [8.8.14] (1-121)-Homo sapiens IGHG1*01, CH2 L1.2>A, G1>A (122-451)], (224-219 )-disulfide with kappa light chain (1 -219 ) [humanized V-KAPPA (Homo sapiens IGKV2-29*02 (84.00%)-IGKJ2*01, L124>V) [11.3.9] (1 -112 )-Homo sapiens IGKC*01 (113 -219 )]; (230-
- Vedolizumab
Andere Arzneimittel
| Bezeichnung | PZN | Form | Verpackung | Hersteller | Preis | |
|---|---|---|---|---|---|---|
| Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P18307236 | PKI | 1 St | HAEMP | € 2440.75 |
| Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P16388271 | PIK | 1 St | NMGPH | € 2439.19 |
| Details | ENTYVIO 108 mg Injektionslösung i.e.Fertigspritze | P17845210 | ILO | 1 St | KOHL | € 625.65 |
| Details | ENTYVIO 108 mg Injektionslösung im Fertigpen | P17571698 | ILO | 6 St | KOHL | € 3632.15 |
| Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P16869378 | PIK | 1 St | ABACU | € 2440.75 |
| Details | ENTYVIO 108 mg Injektionslösung i.e.Fertigspritze | P17822491 | ILO | 6 St | ABACU | € 3632.32 |
| Details | ENTYVIO 108 mg Injektionslösung i.e.Fertigspritze | P15894569 | ILO | 1 St | TAKEK | € 0.00 |
| Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P10272142 | PIK | 1 St | TAKEK | € 0.00 |